Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms, Hereditary Nonpolyposis | 74 | 2023 | 379 | 11.770 |
Why?
|
Germ-Line Mutation | 43 | 2023 | 1786 | 3.530 |
Why?
|
Genetic Testing | 43 | 2022 | 3439 | 3.350 |
Why?
|
Colorectal Neoplasms | 65 | 2023 | 6754 | 3.280 |
Why?
|
DNA Mismatch Repair | 29 | 2023 | 424 | 3.260 |
Why?
|
MutS Homolog 2 Protein | 24 | 2023 | 200 | 2.440 |
Why?
|
Colonoscopy | 25 | 2021 | 1365 | 2.210 |
Why?
|
Pancreatic Neoplasms | 32 | 2022 | 5249 | 2.190 |
Why?
|
Neoplastic Syndromes, Hereditary | 11 | 2023 | 241 | 2.010 |
Why?
|
Adenomatous Polyposis Coli | 10 | 2020 | 224 | 1.900 |
Why?
|
Genetic Predisposition to Disease | 54 | 2023 | 17400 | 1.670 |
Why?
|
Intestinal Polyposis | 7 | 2022 | 44 | 1.570 |
Why?
|
Medical History Taking | 9 | 2021 | 783 | 1.430 |
Why?
|
Microsatellite Instability | 11 | 2023 | 678 | 1.400 |
Why?
|
Hamartoma Syndrome, Multiple | 6 | 2022 | 111 | 1.340 |
Why?
|
DNA Glycosylases | 8 | 2020 | 128 | 1.310 |
Why?
|
Colonic Polyps | 11 | 2020 | 542 | 1.300 |
Why?
|
Peutz-Jeghers Syndrome | 6 | 2022 | 50 | 1.240 |
Why?
|
Risk Assessment | 28 | 2023 | 23320 | 1.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 11 | 2022 | 1631 | 1.080 |
Why?
|
Carcinoma | 10 | 2020 | 2374 | 1.040 |
Why?
|
Early Detection of Cancer | 24 | 2022 | 3070 | 0.990 |
Why?
|
Endometrial Neoplasms | 13 | 2021 | 1351 | 0.960 |
Why?
|
Adaptor Proteins, Signal Transducing | 21 | 2015 | 2915 | 0.950 |
Why?
|
Gastrointestinal Hemorrhage | 10 | 2022 | 1130 | 0.910 |
Why?
|
Models, Genetic | 8 | 2021 | 3493 | 0.910 |
Why?
|
Nuclear Proteins | 24 | 2017 | 5851 | 0.890 |
Why?
|
Pedigree | 23 | 2021 | 4646 | 0.830 |
Why?
|
Li-Fraumeni Syndrome | 4 | 2015 | 114 | 0.820 |
Why?
|
Adenoma | 10 | 2020 | 2168 | 0.820 |
Why?
|
Mass Screening | 19 | 2021 | 5238 | 0.790 |
Why?
|
BRCA2 Protein | 5 | 2021 | 790 | 0.770 |
Why?
|
Colonic Neoplasms | 11 | 2022 | 2542 | 0.720 |
Why?
|
DNA-Binding Proteins | 18 | 2021 | 9639 | 0.710 |
Why?
|
Adenomatous Polyposis Coli Protein | 3 | 2017 | 188 | 0.650 |
Why?
|
Mutation | 35 | 2022 | 29717 | 0.620 |
Why?
|
Genes, APC | 3 | 2020 | 159 | 0.590 |
Why?
|
Colectomy | 8 | 2020 | 681 | 0.590 |
Why?
|
Gastroenterology | 4 | 2016 | 534 | 0.580 |
Why?
|
Adenomatous Polyps | 6 | 2020 | 107 | 0.560 |
Why?
|
BRCA1 Protein | 2 | 2021 | 1145 | 0.560 |
Why?
|
Heterozygote | 16 | 2022 | 2790 | 0.550 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 3 | 2022 | 139 | 0.550 |
Why?
|
Hamartoma | 3 | 2022 | 234 | 0.550 |
Why?
|
Middle Aged | 102 | 2023 | 213127 | 0.530 |
Why?
|
Humans | 199 | 2023 | 742088 | 0.520 |
Why?
|
Neoplasm Proteins | 14 | 2018 | 3691 | 0.500 |
Why?
|
Neoplasms | 14 | 2022 | 21596 | 0.500 |
Why?
|
Predictive Value of Tests | 19 | 2020 | 15056 | 0.480 |
Why?
|
Male | 110 | 2023 | 349538 | 0.450 |
Why?
|
Female | 117 | 2023 | 379592 | 0.440 |
Why?
|
Adult | 84 | 2021 | 213712 | 0.420 |
Why?
|
DNA Mutational Analysis | 11 | 2017 | 4187 | 0.410 |
Why?
|
Watchful Waiting | 3 | 2021 | 491 | 0.410 |
Why?
|
Base Pair Mismatch | 3 | 2012 | 97 | 0.410 |
Why?
|
DNA, Neoplasm | 6 | 2012 | 1758 | 0.410 |
Why?
|
Aged | 76 | 2021 | 162944 | 0.400 |
Why?
|
Genes, BRCA2 | 5 | 2019 | 617 | 0.380 |
Why?
|
Feces | 3 | 2006 | 1394 | 0.380 |
Why?
|
Jews | 3 | 2020 | 385 | 0.380 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2017 | 2948 | 0.370 |
Why?
|
Intention | 2 | 2014 | 338 | 0.360 |
Why?
|
Gastrointestinal Tract | 1 | 2016 | 814 | 0.350 |
Why?
|
Medical Oncology | 3 | 2016 | 2235 | 0.350 |
Why?
|
Risk Factors | 36 | 2021 | 72145 | 0.340 |
Why?
|
Standard of Care | 2 | 2012 | 562 | 0.330 |
Why?
|
Lower Gastrointestinal Tract | 2 | 2005 | 14 | 0.330 |
Why?
|
Logistic Models | 11 | 2017 | 13403 | 0.320 |
Why?
|
Radiotherapy | 2 | 2020 | 1525 | 0.310 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2013 | 719 | 0.310 |
Why?
|
Genes, BRCA1 | 3 | 2017 | 780 | 0.310 |
Why?
|
Occult Blood | 3 | 2021 | 176 | 0.310 |
Why?
|
Genetic Counseling | 5 | 2021 | 600 | 0.310 |
Why?
|
Endoscopy, Digestive System | 2 | 2014 | 345 | 0.300 |
Why?
|
Aged, 80 and over | 32 | 2021 | 57683 | 0.300 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1327 | 0.290 |
Why?
|
Pancreatic Cyst | 4 | 2021 | 368 | 0.290 |
Why?
|
Endosonography | 4 | 2021 | 610 | 0.290 |
Why?
|
Proto-Oncogene Proteins | 7 | 2014 | 4553 | 0.280 |
Why?
|
Colonic Diseases | 1 | 2008 | 202 | 0.280 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11363 | 0.270 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 376 | 0.270 |
Why?
|
Microsatellite Repeats | 8 | 2012 | 800 | 0.270 |
Why?
|
Colorectal Surgery | 2 | 2020 | 129 | 0.270 |
Why?
|
Age Factors | 10 | 2021 | 18355 | 0.270 |
Why?
|
DNA Repair | 4 | 2018 | 2042 | 0.260 |
Why?
|
Germ Cells | 4 | 2021 | 628 | 0.260 |
Why?
|
Carrier Proteins | 10 | 2014 | 5019 | 0.260 |
Why?
|
Pancreatic Juice | 3 | 2014 | 62 | 0.260 |
Why?
|
Patient Compliance | 2 | 2013 | 2680 | 0.260 |
Why?
|
Rectal Neoplasms | 2 | 2005 | 1195 | 0.260 |
Why?
|
Neoplasms, Multiple Primary | 4 | 2016 | 600 | 0.260 |
Why?
|
Heredity | 5 | 2021 | 154 | 0.260 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2016 | 1769 | 0.250 |
Why?
|
Cross-Sectional Studies | 14 | 2021 | 24913 | 0.250 |
Why?
|
Phenotype | 14 | 2021 | 16331 | 0.250 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2009 | 505 | 0.250 |
Why?
|
Genes, p53 | 2 | 2008 | 755 | 0.240 |
Why?
|
Prenatal Diagnosis | 2 | 2011 | 1232 | 0.240 |
Why?
|
Awareness | 1 | 2008 | 639 | 0.230 |
Why?
|
Aftercare | 2 | 2020 | 860 | 0.230 |
Why?
|
Anxiety | 1 | 2018 | 4279 | 0.230 |
Why?
|
Carcinoma, Papillary | 1 | 2009 | 781 | 0.230 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2019 | 3471 | 0.230 |
Why?
|
Founder Effect | 1 | 2004 | 190 | 0.230 |
Why?
|
Minority Groups | 2 | 2008 | 1215 | 0.230 |
Why?
|
Fibromatosis, Aggressive | 1 | 2004 | 118 | 0.230 |
Why?
|
Precancerous Conditions | 3 | 2021 | 971 | 0.230 |
Why?
|
Sequence Analysis, DNA | 5 | 2019 | 4801 | 0.220 |
Why?
|
Cohort Studies | 19 | 2021 | 40450 | 0.220 |
Why?
|
Stress, Psychological | 1 | 2018 | 4229 | 0.220 |
Why?
|
Stomach Diseases | 2 | 2020 | 134 | 0.220 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2016 | 602 | 0.210 |
Why?
|
Disclosure | 1 | 2008 | 736 | 0.200 |
Why?
|
Risk | 7 | 2018 | 9679 | 0.200 |
Why?
|
Family Health | 4 | 2011 | 1282 | 0.200 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2004 | 436 | 0.200 |
Why?
|
Tumor Suppressor Proteins | 4 | 2017 | 2842 | 0.200 |
Why?
|
Models, Statistical | 4 | 2022 | 5100 | 0.200 |
Why?
|
Young Adult | 16 | 2021 | 56350 | 0.200 |
Why?
|
Poverty | 3 | 2014 | 2646 | 0.190 |
Why?
|
Sulindac | 1 | 2020 | 29 | 0.190 |
Why?
|
Eflornithine | 1 | 2020 | 31 | 0.190 |
Why?
|
Advisory Committees | 6 | 2020 | 773 | 0.190 |
Why?
|
Population Surveillance | 5 | 2019 | 2616 | 0.190 |
Why?
|
Family | 3 | 2017 | 3144 | 0.190 |
Why?
|
DNA Repair Enzymes | 4 | 2016 | 349 | 0.190 |
Why?
|
Pancreas | 5 | 2022 | 1684 | 0.190 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 96 | 0.180 |
Why?
|
Penetrance | 3 | 2017 | 380 | 0.180 |
Why?
|
Polyps | 3 | 2012 | 189 | 0.180 |
Why?
|
Social Class | 2 | 2009 | 1995 | 0.180 |
Why?
|
Smad4 Protein | 1 | 2020 | 163 | 0.180 |
Why?
|
Practice Guidelines as Topic | 5 | 2020 | 7276 | 0.180 |
Why?
|
Sex Factors | 7 | 2021 | 10392 | 0.180 |
Why?
|
Intestinal Diseases | 1 | 2005 | 531 | 0.180 |
Why?
|
Prenylation | 1 | 2019 | 37 | 0.180 |
Why?
|
Breast Neoplasms | 8 | 2022 | 20774 | 0.170 |
Why?
|
Adenocarcinoma | 5 | 2019 | 6347 | 0.170 |
Why?
|
Insurance, Health | 2 | 2009 | 2493 | 0.170 |
Why?
|
Genes, p16 | 2 | 2017 | 157 | 0.170 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 1683 | 0.170 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 319 | 0.170 |
Why?
|
Carboxypeptidase B | 1 | 2018 | 6 | 0.160 |
Why?
|
Carboxypeptidases A | 1 | 2018 | 49 | 0.160 |
Why?
|
Gene Frequency | 4 | 2020 | 3587 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2018 | 8425 | 0.160 |
Why?
|
Neuroendocrine Tumors | 2 | 2021 | 594 | 0.160 |
Why?
|
ROC Curve | 4 | 2017 | 3528 | 0.160 |
Why?
|
United States | 23 | 2021 | 69693 | 0.160 |
Why?
|
Intestinal Polyps | 3 | 2022 | 99 | 0.160 |
Why?
|
Patient Selection | 2 | 2009 | 4214 | 0.150 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 246 | 0.150 |
Why?
|
Prognosis | 9 | 2022 | 29010 | 0.150 |
Why?
|
Cholelithiasis | 1 | 1999 | 411 | 0.150 |
Why?
|
Parents | 2 | 2011 | 3387 | 0.150 |
Why?
|
SEER Program | 3 | 2009 | 1507 | 0.150 |
Why?
|
Prevalence | 10 | 2021 | 15194 | 0.150 |
Why?
|
Cholecystectomy | 1 | 1999 | 387 | 0.150 |
Why?
|
Cell Adhesion Molecules | 3 | 2014 | 1599 | 0.140 |
Why?
|
Proctocolectomy, Restorative | 1 | 1998 | 189 | 0.140 |
Why?
|
Adolescent | 13 | 2021 | 85649 | 0.140 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13655 | 0.140 |
Why?
|
Multivariate Analysis | 7 | 2012 | 12242 | 0.140 |
Why?
|
Sequence Deletion | 2 | 2011 | 1526 | 0.140 |
Why?
|
Decision Support Techniques | 2 | 2004 | 1952 | 0.140 |
Why?
|
Private Practice | 1 | 2016 | 154 | 0.140 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1831 | 0.130 |
Why?
|
Adenosine Triphosphatases | 3 | 2015 | 836 | 0.130 |
Why?
|
Inheritance Patterns | 1 | 2018 | 340 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2015 | 3915 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 316 | 0.130 |
Why?
|
Medical Records | 3 | 2007 | 1413 | 0.130 |
Why?
|
Intestine, Small | 1 | 2021 | 1243 | 0.130 |
Why?
|
Consensus | 6 | 2020 | 2935 | 0.130 |
Why?
|
Genetic Markers | 2 | 2011 | 2633 | 0.130 |
Why?
|
Muir-Torre Syndrome | 1 | 2014 | 13 | 0.130 |
Why?
|
Antigens, Neoplasm | 3 | 2014 | 1983 | 0.130 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2015 | 704 | 0.130 |
Why?
|
Social Behavior | 1 | 2021 | 1128 | 0.130 |
Why?
|
Risk Reduction Behavior | 1 | 2021 | 1123 | 0.130 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 314 | 0.130 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2015 | 101 | 0.120 |
Why?
|
Attitude | 2 | 2011 | 772 | 0.120 |
Why?
|
Sample Size | 1 | 2017 | 844 | 0.120 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2275 | 0.120 |
Why?
|
Sensitivity and Specificity | 9 | 2012 | 14720 | 0.120 |
Why?
|
Likelihood Functions | 2 | 2007 | 1003 | 0.120 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2014 | 111 | 0.120 |
Why?
|
Ampulla of Vater | 1 | 2014 | 141 | 0.110 |
Why?
|
Reproducibility of Results | 6 | 2019 | 19862 | 0.110 |
Why?
|
California | 1 | 2017 | 1400 | 0.110 |
Why?
|
Age of Onset | 4 | 2015 | 3266 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2006 | 7901 | 0.110 |
Why?
|
Pancreatic Ducts | 1 | 2015 | 328 | 0.110 |
Why?
|
Endoscopy | 1 | 2022 | 1774 | 0.110 |
Why?
|
Program Development | 1 | 2019 | 1314 | 0.110 |
Why?
|
Biomedical Research | 2 | 2019 | 3306 | 0.110 |
Why?
|
Ovarian Neoplasms | 3 | 2021 | 4823 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3585 | 0.110 |
Why?
|
Incidence | 7 | 2023 | 20928 | 0.110 |
Why?
|
Chemoprevention | 2 | 2005 | 319 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.100 |
Why?
|
Registries | 4 | 2015 | 8077 | 0.100 |
Why?
|
ras Proteins | 2 | 2014 | 1060 | 0.100 |
Why?
|
Health Status Disparities | 2 | 2021 | 1794 | 0.100 |
Why?
|
Ataxia Telangiectasia | 1 | 2011 | 107 | 0.100 |
Why?
|
Brain Neoplasms | 4 | 2022 | 8829 | 0.100 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7770 | 0.100 |
Why?
|
Severity of Illness Index | 4 | 2016 | 15530 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2015 | 987 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2019 | 3527 | 0.090 |
Why?
|
Follow-Up Studies | 8 | 2021 | 39004 | 0.090 |
Why?
|
Demography | 2 | 2007 | 1650 | 0.090 |
Why?
|
Dysplastic Nevus Syndrome | 1 | 2010 | 63 | 0.090 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2012 | 202 | 0.090 |
Why?
|
Markov Chains | 3 | 2007 | 969 | 0.090 |
Why?
|
Galactose Oxidase | 1 | 2010 | 14 | 0.090 |
Why?
|
RNA Splice Sites | 1 | 2011 | 209 | 0.090 |
Why?
|
Rectum | 2 | 2010 | 903 | 0.090 |
Why?
|
Attitude to Health | 1 | 2019 | 2051 | 0.090 |
Why?
|
Galactans | 1 | 2010 | 31 | 0.090 |
Why?
|
Regression Analysis | 2 | 2017 | 6452 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2699 | 0.090 |
Why?
|
Antigens, Viral, Tumor | 1 | 2010 | 154 | 0.090 |
Why?
|
Protein Array Analysis | 1 | 2011 | 411 | 0.090 |
Why?
|
Length of Stay | 1 | 2003 | 6294 | 0.090 |
Why?
|
Genotype | 3 | 2016 | 12946 | 0.090 |
Why?
|
Disaccharides | 1 | 2010 | 172 | 0.090 |
Why?
|
Diagnosis, Differential | 6 | 2014 | 12958 | 0.090 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2011 | 253 | 0.090 |
Why?
|
DNA Methylation | 5 | 2017 | 4282 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2012 | 365 | 0.080 |
Why?
|
Hypovolemia | 1 | 2008 | 45 | 0.080 |
Why?
|
Lod Score | 2 | 2007 | 615 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2021 | 77098 | 0.080 |
Why?
|
Zea mays | 1 | 2008 | 105 | 0.080 |
Why?
|
Syndrome | 2 | 2005 | 3248 | 0.080 |
Why?
|
Prospective Studies | 10 | 2021 | 53187 | 0.080 |
Why?
|
Quality-Adjusted Life Years | 3 | 2010 | 1679 | 0.080 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5662 | 0.080 |
Why?
|
Gastric Fistula | 1 | 2008 | 73 | 0.080 |
Why?
|
Intestinal Mucosa | 4 | 2020 | 3038 | 0.080 |
Why?
|
Fundoplication | 1 | 2008 | 138 | 0.080 |
Why?
|
Weight Loss | 1 | 1999 | 2604 | 0.080 |
Why?
|
Gene Dosage | 1 | 2012 | 1251 | 0.080 |
Why?
|
DNA | 3 | 2014 | 7289 | 0.070 |
Why?
|
Pancreatitis, Chronic | 1 | 2010 | 285 | 0.070 |
Why?
|
Moral Obligations | 1 | 2008 | 96 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2527 | 0.070 |
Why?
|
Disease Progression | 2 | 2021 | 13256 | 0.070 |
Why?
|
Pericarditis | 1 | 2008 | 128 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 9941 | 0.070 |
Why?
|
Diverticulitis, Colonic | 1 | 2008 | 127 | 0.070 |
Why?
|
Societies, Medical | 4 | 2020 | 3740 | 0.070 |
Why?
|
Genetic Services | 1 | 2006 | 14 | 0.070 |
Why?
|
Public Housing | 1 | 2008 | 145 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3957 | 0.070 |
Why?
|
Pilot Projects | 3 | 2009 | 8297 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2012 | 6171 | 0.070 |
Why?
|
Tomography, Spiral Computed | 1 | 2008 | 279 | 0.070 |
Why?
|
Nuts | 1 | 2008 | 257 | 0.070 |
Why?
|
Diverticulitis | 1 | 2008 | 169 | 0.070 |
Why?
|
Coloring Agents | 1 | 2008 | 565 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 374 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2011 | 12344 | 0.070 |
Why?
|
Whole Body Imaging | 1 | 2008 | 280 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2004 | 5724 | 0.070 |
Why?
|
Chi-Square Distribution | 2 | 2012 | 3510 | 0.070 |
Why?
|
Alleles | 4 | 2016 | 6931 | 0.070 |
Why?
|
Survivors | 1 | 2016 | 2286 | 0.070 |
Why?
|
Population Groups | 1 | 2006 | 208 | 0.060 |
Why?
|
Obesity | 3 | 2023 | 12705 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.060 |
Why?
|
Blood Coagulation Disorders | 1 | 2008 | 337 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2015 | 2536 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11039 | 0.060 |
Why?
|
Area Under Curve | 3 | 2015 | 1653 | 0.060 |
Why?
|
Life Expectancy | 2 | 2004 | 1183 | 0.060 |
Why?
|
Early Diagnosis | 2 | 2012 | 1184 | 0.060 |
Why?
|
Communication Barriers | 1 | 2008 | 398 | 0.060 |
Why?
|
Neoplasm Staging | 4 | 2019 | 11001 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 2853 | 0.060 |
Why?
|
Chromosomal Instability | 1 | 2005 | 184 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2450 | 0.060 |
Why?
|
Family Practice | 1 | 2007 | 516 | 0.060 |
Why?
|
Secretin | 2 | 2015 | 57 | 0.060 |
Why?
|
Life Tables | 1 | 2004 | 370 | 0.060 |
Why?
|
Colostomy | 1 | 2004 | 98 | 0.060 |
Why?
|
Time Factors | 6 | 2021 | 40054 | 0.060 |
Why?
|
Morbidity | 1 | 2009 | 1767 | 0.060 |
Why?
|
Algorithms | 5 | 2014 | 13853 | 0.060 |
Why?
|
Hospitals | 1 | 2016 | 3937 | 0.050 |
Why?
|
Tumor Burden | 2 | 2021 | 1905 | 0.050 |
Why?
|
Odds Ratio | 3 | 2020 | 9846 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3612 | 0.050 |
Why?
|
Frameshift Mutation | 1 | 2004 | 399 | 0.050 |
Why?
|
Australia | 2 | 2015 | 1167 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2008 | 2970 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3328 | 0.050 |
Why?
|
Outpatients | 1 | 2009 | 1483 | 0.050 |
Why?
|
Gastroesophageal Reflux | 1 | 2008 | 782 | 0.050 |
Why?
|
Research Personnel | 1 | 2006 | 573 | 0.050 |
Why?
|
Clinical Competence | 1 | 2016 | 4681 | 0.050 |
Why?
|
Gene Deletion | 2 | 2010 | 2751 | 0.050 |
Why?
|
Base Sequence | 3 | 2011 | 12797 | 0.050 |
Why?
|
Probability | 1 | 2006 | 2502 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9144 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 2276 | 0.050 |
Why?
|
Documentation | 1 | 2007 | 865 | 0.050 |
Why?
|
Vitamins | 1 | 2009 | 1608 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 2027 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3444 | 0.050 |
Why?
|
Educational Status | 1 | 2008 | 2533 | 0.050 |
Why?
|
Income | 1 | 2009 | 1904 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2002 | 678 | 0.040 |
Why?
|
Genetic Variation | 2 | 2016 | 6540 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2019 | 13814 | 0.040 |
Why?
|
Barrett Esophagus | 1 | 2004 | 494 | 0.040 |
Why?
|
Education, Medical, Graduate | 1 | 2012 | 2283 | 0.040 |
Why?
|
Sequence Homology | 1 | 2019 | 203 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 425 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2021 | 35342 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 18112 | 0.040 |
Why?
|
Ischemia | 1 | 2008 | 1911 | 0.040 |
Why?
|
Child | 5 | 2023 | 77478 | 0.040 |
Why?
|
Angiography | 1 | 2005 | 1636 | 0.040 |
Why?
|
Gastric Mucosa | 2 | 2020 | 598 | 0.040 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9410 | 0.040 |
Why?
|
Survival Analysis | 2 | 2019 | 10248 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2016 | 21719 | 0.040 |
Why?
|
Internet | 2 | 2012 | 3062 | 0.040 |
Why?
|
Anticarcinogenic Agents | 1 | 2000 | 253 | 0.040 |
Why?
|
Spain | 2 | 2010 | 465 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3507 | 0.040 |
Why?
|
Data Collection | 1 | 2007 | 3339 | 0.040 |
Why?
|
Health Behavior | 1 | 2009 | 2630 | 0.040 |
Why?
|
Motivation | 2 | 2004 | 1968 | 0.040 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2004 | 933 | 0.040 |
Why?
|
Decision Making | 2 | 2011 | 3869 | 0.040 |
Why?
|
Neoplasms, Second Primary | 1 | 2005 | 1052 | 0.040 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1997 | 287 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3639 | 0.040 |
Why?
|
Counseling | 1 | 2004 | 1521 | 0.040 |
Why?
|
Health Literacy | 1 | 2021 | 414 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 736 | 0.030 |
Why?
|
Ileum | 1 | 1998 | 565 | 0.030 |
Why?
|
Specimen Handling | 1 | 2020 | 692 | 0.030 |
Why?
|
Sulfasalazine | 1 | 2016 | 79 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3611 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9185 | 0.030 |
Why?
|
DNA Modification Methylases | 1 | 2016 | 206 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 497 | 0.030 |
Why?
|
Health Care Surveys | 2 | 2016 | 2451 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 2016 | 156 | 0.030 |
Why?
|
Fungal Proteins | 1 | 1999 | 912 | 0.030 |
Why?
|
MicroRNAs | 1 | 2011 | 3731 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1998 | 985 | 0.030 |
Why?
|
Transition Temperature | 1 | 2014 | 36 | 0.030 |
Why?
|
Acute Disease | 1 | 2005 | 7141 | 0.030 |
Why?
|
New Zealand | 1 | 2015 | 357 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 12730 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2020 | 62966 | 0.030 |
Why?
|
Hospitals, Community | 1 | 2016 | 348 | 0.030 |
Why?
|
Esophageal Neoplasms | 1 | 2004 | 1581 | 0.030 |
Why?
|
Digestive System | 1 | 1995 | 251 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 106 | 0.030 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2018 | 589 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10372 | 0.030 |
Why?
|
Puerto Rico | 1 | 2014 | 356 | 0.030 |
Why?
|
Health Planning | 1 | 2015 | 237 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4328 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2019 | 802 | 0.030 |
Why?
|
Terminology as Topic | 1 | 2020 | 1548 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 1997 | 1097 | 0.030 |
Why?
|
Life Style | 1 | 2004 | 3824 | 0.030 |
Why?
|
Promoter Regions, Genetic | 3 | 2011 | 5867 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2009 | 13921 | 0.030 |
Why?
|
Sex Distribution | 1 | 1998 | 2295 | 0.030 |
Why?
|
North America | 1 | 2015 | 1249 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2010 | 5385 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6259 | 0.030 |
Why?
|
Health Surveys | 2 | 2015 | 4030 | 0.030 |
Why?
|
Age Distribution | 1 | 1998 | 2900 | 0.030 |
Why?
|
Infant | 1 | 2013 | 35070 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2458 | 0.030 |
Why?
|
Chromogranins | 1 | 2012 | 163 | 0.030 |
Why?
|
Boston | 1 | 2004 | 9305 | 0.020 |
Why?
|
Cecum | 1 | 2012 | 237 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 159 | 0.020 |
Why?
|
Intubation, Gastrointestinal | 1 | 2012 | 153 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1021 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2021 | 4839 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1058 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 944 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2012 | 500 | 0.020 |
Why?
|
Research Design | 1 | 2006 | 5979 | 0.020 |
Why?
|
Point Mutation | 1 | 2015 | 1624 | 0.020 |
Why?
|
Rosaniline Dyes | 1 | 2010 | 51 | 0.020 |
Why?
|
Diet | 1 | 2008 | 7923 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6483 | 0.020 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2010 | 56 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2005 | 2410 | 0.020 |
Why?
|
Michigan | 1 | 2010 | 350 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 1999 | 1884 | 0.020 |
Why?
|
Canada | 1 | 2015 | 2061 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2020 | 6534 | 0.020 |
Why?
|
Haplotypes | 2 | 2011 | 2781 | 0.020 |
Why?
|
Italy | 1 | 2011 | 828 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20086 | 0.020 |
Why?
|
Pregnancy | 2 | 2011 | 29087 | 0.020 |
Why?
|
Germany | 1 | 2011 | 860 | 0.020 |
Why?
|
Duodenum | 1 | 2012 | 483 | 0.020 |
Why?
|
Women | 1 | 2011 | 230 | 0.020 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2010 | 176 | 0.020 |
Why?
|
Europe | 1 | 2015 | 3339 | 0.020 |
Why?
|
Asymptomatic Diseases | 1 | 2012 | 552 | 0.020 |
Why?
|
Weight Gain | 1 | 1999 | 2282 | 0.020 |
Why?
|
Introns | 1 | 2011 | 991 | 0.020 |
Why?
|
Hospitalization | 1 | 2008 | 10232 | 0.020 |
Why?
|
Women's Health | 1 | 1998 | 2034 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 2990 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2010 | 338 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6891 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2008 | 587 | 0.020 |
Why?
|
Binding Sites | 1 | 2016 | 6115 | 0.020 |
Why?
|
Waist-Hip Ratio | 1 | 2008 | 517 | 0.020 |
Why?
|
Body Mass Index | 2 | 2008 | 12695 | 0.020 |
Why?
|
Feeding Behavior | 1 | 1999 | 3187 | 0.020 |
Why?
|
Hysterectomy | 1 | 2012 | 927 | 0.020 |
Why?
|
Netherlands | 1 | 2011 | 2170 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 1998 | 1901 | 0.020 |
Why?
|
Genomic Instability | 1 | 2010 | 695 | 0.020 |
Why?
|
Exons | 1 | 2011 | 2431 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1208 | 0.020 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12220 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2015 | 2211 | 0.020 |
Why?
|
Acrylamide | 1 | 2004 | 60 | 0.020 |
Why?
|
Waist Circumference | 1 | 2008 | 917 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2016 | 15494 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2906 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2016 | 3391 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1114 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10472 | 0.010 |
Why?
|
Survival Rate | 1 | 1998 | 12773 | 0.010 |
Why?
|
Fellowships and Scholarships | 1 | 2012 | 1066 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4420 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2014 | 3584 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2007 | 1254 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16665 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6191 | 0.010 |
Why?
|
Magnetics | 1 | 2004 | 609 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2007 | 2422 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2749 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2028 | 0.010 |
Why?
|
Genomics | 1 | 2015 | 5692 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2013 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8333 | 0.010 |
Why?
|
Cooperative Behavior | 1 | 2006 | 1503 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5133 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5062 | 0.010 |
Why?
|
CpG Islands | 1 | 2002 | 1170 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40955 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2658 | 0.010 |
Why?
|
Endoscopes | 1 | 1998 | 174 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4465 | 0.010 |
Why?
|
Genome | 1 | 2004 | 1803 | 0.010 |
Why?
|
Health Status | 1 | 2009 | 4030 | 0.010 |
Why?
|
Mammography | 1 | 2003 | 2474 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15244 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168561 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1995 | 1167 | 0.000 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3695 | 0.000 |
Why?
|